Literature DB >> 15799818

Titanium cage-assisted polymethylmethacrylate reconstruction for cervical spinal metastasis: technical note.

James K Liu1, William S Rosenberg, Meic H Schmidt.   

Abstract

OBJECTIVE: Reconstruction and stabilization of the cervical spine after vertebrectomy is an important goal in the surgical management of spinal metastasis. The authors describe their reconstruction technique using a titanium cage-Silastic tube construct injected with polymethylmethacrylate (PMMA) augmented by an anterior cervical plate. The surgical results using this technique are reviewed.
METHODS: Six patients ranging from 43 to 70 years of age underwent resection of metastatic tumor in the cervical spine followed by cage-assisted PMMA reconstruction of the anterior spinal column. The following reconstruction technique was performed. A Silastic tube is incised longitudinally and placed circumferentially around a titanium cage with the opening facing anteriorly. The cage-Silastic tube construct is carefully tapped into the corpectomy defect and filled with PMMA. The final construct is then augmented with anterior cervical plate fixation.
RESULTS: Two patients required additional posterior stabilization with lateral mass screws and rods. All patients achieved immediate stabilization, restoration of vertebral body height and normal lordosis, and preservation of the ability to walk independently. Five patients experienced significant palliation of biomechanical neck pain. There were no complications of neurological worsening, postoperative hematoma, wound infection, subsidence, graft dislodgement, or construct failure during a follow-up period of 1 to 19 months (mean, 6.8 mo).
CONCLUSION: Titanium cage-assisted PMMA reconstruction augmented with an anterior cervical plate is an effective means of reconstruction after tumor resection in patients with cervical spinal metastasis. The Silastic tube holds the PMMA within the cage and protects the spinal cord from potential thermal injury.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15799818     DOI: 10.1227/01.neu.0000144494.12738.81

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  7 in total

Review 1.  Cervical spine metastases: techniques for anterior reconstruction and stabilization.

Authors:  Christina M Sayama; Meic H Schmidt; Erica F Bisson
Journal:  Neurosurg Rev       Date:  2012-04-29       Impact factor: 3.042

2.  Hemangiopericytomas of the spine: case report and review of the literature.

Authors:  Chad D Cole; Meic H Schmidt
Journal:  Rare Tumors       Date:  2009-12-28

3.  Analysis of prognostic factors relating to postoperative survival in spinal metastases.

Authors:  Soon Bum Yang; Wonik Cho; Ung-Kyu Chang
Journal:  J Korean Neurosurg Soc       Date:  2012-03-31

4.  Clinical significance of radiological stability in reconstructed thoracic and lumbar spine following vertebral body resection.

Authors:  Sang-Hyun Sung; Ung-Kyu Chang
Journal:  J Korean Neurosurg Soc       Date:  2014-10-31

5.  Surgical or Radiation Therapy for the Treatment of Cervical Spine Metastases: Results From the Epidemiology, Process, and Outcomes of Spine Oncology (EPOSO) Cohort.

Authors:  Michael R Bond; Anne L Versteeg; Arjun Sahgal; Laurence D Rhines; Daniel M Sciubba; James M Schuster; Michael H Weber; Michael G Fehlings; Aron Lazary; Michelle J Clarke; Stefano Boriani; Chetan Bettegowda; Paul M Arnold; Ziya L Gokaslan; Charles G Fisher
Journal:  Global Spine J       Date:  2019-03-31

6.  Treatment of cervical vertebral (C1) metastasis of lung cancer with radiotherapy: A case report.

Authors:  Xuefeng Ni; Ping Wu; Changping Wu; Jianfeng Wu; Mei Ji; Xiaofang Gu; Bo Tian
Journal:  Oncol Lett       Date:  2013-02-06       Impact factor: 2.967

7.  Anterior Corpectomy and Plating with Carbon-PEEK Instrumentation for Cervical Spinal Metastases: Clinical and Radiological Outcomes.

Authors:  Sokol Trungu; Luca Ricciardi; Stefano Forcato; Antonio Scollato; Giuseppe Minniti; Massimo Miscusi; Antonino Raco
Journal:  J Clin Med       Date:  2021-12-16       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.